During the past decade, Montgomery Kidney Specialists conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montgomery Kidney Specialists" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Montgomery Kidney Specialists" are "Chronic Kidney Disease" (1 trials), "Chronic Renal Failure" (1 trials) and "Hyperphosphatemia" (1 trials). Many other conditions were trialed in "Montgomery Kidney Specialists" in a lesser frequency.

Most popular intervention types in "Montgomery Kidney Specialists" are "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Epoetin Hospira" (1 trials) and "Epogen (Amgen)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montgomery Kidney Specialists" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Montgomery Kidney Specialists". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Montgomery Kidney Specialists, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montgomery Kidney Specialists, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".